DEMECAN
PrivateLast Round
VC Round
Aug 7, 2024
Est. Valuation
$109.2M
Total Funding Raised
$7.63M
Company Overview
DEMECAN is a pharmaceuticals and biotechnology company that produces, imports, and supplies medical cannabis in Germany.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DEMECAN Comparables
Compare DEMECAN with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Semdor Pharma Group | 84% | |
| SOMAÍ Pharmaceuticals | 83% | |
| enua Pharma GmbH | 83% | |
DEMECAN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 7, 2024 | ||||
| VC Round | Dec 19, 2022 | ||||
| VC Round | Apr 15, 2021 | ||||
| Series A Extension | May 19, 2020 | ||||
| Series A | Oct 1, 2019 |
Key People
Founding team and executive leadership
DEMECAN Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mittelständische Beteiligungsgesellschaft Sachsen | VC Round |
| Futury Capital | VC Round |
| b2venture | VC Round, Series A |
| Future Capital AG | Series A |
| Trog Hawley Capital | VC Round |
| ENEXIS | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
Expanding cultivation at Ebersbach site to boost domestic production capacity.
- Apr 15, 2021
$9.6M round led by Futury Capital.
DEMECAN Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DEMECAN's valuation, stock price, and market status.